Literature DB >> 19474279

Congenital disorders of glycosylation: a rare cause of nephrotic syndrome.

Manish D Sinha1, Catherine Horsfield, Debbie Komaromy, Caroline J Booth, Michael P Champion.   

Abstract

Congenital disorders of glycosylation (CDG) are inborn errors of metabolism presenting with multi-system organ involvement due to defective glycosylation of glycoproteins. We report here a case of microcephaly, hypotonia, seizure disorder and severe developmental delay since infancy in whom screening for CDG with transferring isoelectric focussing (TIEF) revealed a type I pattern. Following investigation, the specific defect in glycosylation remains to be identified; hence, a diagnosis of CDG Ix (type unknown) was made. At the age of 15-months the patient developed nephrotic syndrome and renal biopsy indicated a histopathological diagnosis of diffuse mesangial sclerosis on histopathology. Since cases of CDG Ix may often develop hypoalbuminaemia secondary to malabsorption or liver disease, this case highlights the need for additional regular monitoring for glomerular proteinuria, and indicates that a diagnosis of nephrotic syndrome should be considered in all types of CDG. Furthermore, we propose that early treatment with anti-proteinuric agents may be necessary to limit proteinuria and slow disease progression.

Entities:  

Mesh:

Year:  2009        PMID: 19474279     DOI: 10.1093/ndt/gfp226

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  3 in total

1.  Congenital nephrotic syndrome with dysmorphic features and death in early infancy: Answers.

Authors:  Julien Heinrich Park; Martin Weissensteiner; Oliver Wagner; Yoshinao Wada; Stephan Rust; Janine Reunert; Thorsten Marquardt
Journal:  Pediatr Nephrol       Date:  2015-05-09       Impact factor: 3.714

2.  Congenital nephrotic syndrome in an infant with ALG1-congenital disorder of glycosylation.

Authors:  Lyndsay A Harshman; Bobby G Ng; Hudson H Freeze; Pamela Trapane; Anna Dolezal; Patrick D Brophy; Jane E Brumbaugh
Journal:  Pediatr Int       Date:  2016-06-21       Impact factor: 1.524

3.  Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.

Authors:  Kristina M Niculovic; Linda Blume; Henri Wedekind; Elina Kats; Iris Albers; Stephanie Groos; Markus Abeln; Jessica Schmitz; Esther Beuke; Jan H Bräsen; Anette Melk; Mario Schiffer; Birgit Weinhold; Anja K Münster-Kühnel
Journal:  J Am Soc Nephrol       Date:  2019-04-30       Impact factor: 10.121

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.